A
Anzelika Rubina
Researcher at Cardiff University
Publications - 10
Citations - 115
Anzelika Rubina is an academic researcher from Cardiff University. The author has contributed to research in topics: Biology & Medicine. The author has an hindex of 3, co-authored 4 publications receiving 33 citations.
Papers
More filters
Journal ArticleDOI
IL-33 Augments Virus-Specific Memory T Cell Inflation and Potentiates the Efficacy of an Attenuated Cytomegalovirus-Based Vaccine.
James E. McLaren,Mathew Clement,Morgan Marsden,Kelly L. Miners,Sian Llewellyn-Lacey,Emma J. Grant,Emma J. Grant,Anzelika Rubina,Silvia Gimeno Brias,Emma Gostick,Maria A. Stacey,Selinda J. Orr,Richard J. Stanton,Kristin Ladell,David Price,Ian R. Humphreys,Ian R. Humphreys +16 more
TL;DR: It is shown that IL-33 promotes the accumulation and recall kinetics of circulating and tissue-resident memory T cells in mice infected with murine CMV, and this data suggest thatIL-33 could serve as a useful adjuvant to improve the efficacy of vaccines based on attenuated derivatives of CMV.
Journal ArticleDOI
The SARS-CoV2 envelope differs from host cells, exposes procoagulant lipids, and is disrupted in vivo by oral rinses
Andreas Zaragkoulias,Evelina Statkute,Kirsten Bentley,Patricia Rodrigues,Robert G. Newcombe,James E. Heyman,Arvind Arya,Ceri Lynch,David Owens,P. Vince Jenkins,David Thomas,Richard J. Stanton,Zack Saud,Victoria J. Tyrrell,Majd B. Protty,Anzelika Rubina,Daniel A. White,Robert C. Murphy,Harald Köfeler,William J. Griffiths,Jorge Alvarez-Jarreta,Richard W. Brown,Manon F. Pritchard,Robert McLeod,Niklaas J. Buurma,Valerie B. O'Donnell +25 more
TL;DR: The lipid envelope of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an essential component of the virus; however, its molecular composition is undetermined as discussed by the authors .
Journal ArticleDOI
Ozone for SARS-CoV-2 inactivation on surfaces and in liquid cell culture media
Chedly Tizaoui,Richard Stanton,Evelina Statkute,Anzelika Rubina,Edward Lester-Card,Anthony Lewis,Peter J. Holliman,David A. Worsley +7 more
TL;DR: Through careful choice of (CT, RH), gaseous ozone is effective against SARS-CoV-2 and the results are of significance to a growing field where ozone is applied to control the spread of COVID-19.
Journal ArticleDOI
The SARS-CoV2 envelope differs from host cells, exposes procoagulant lipids, and is disrupted in vivo by oral rinses
Zack Saud,Victoria J. Tyrrell,Kirsten Bentley,Patricia Rodrigues,Robert C. Murphy,Harald Köfeler,William J. Griffiths,Jorge Alvarez-Jarreta,Richard W. Brown,Robert G. Newcombe,James E. Heyman,Robert McLeod,David Owens,P. Vince Jenkins,Niklaas J. Buurma,Valerie B. O'Donnell,Andreas Zaragkoulias,Majd B. Protty,Evelina Statkute,Anzelika Rubina,Daniel A. White,Manon F. Pritchard,Arvind Arya,Ceri Lynch,David Thomas,Richard J. Stanton +25 more
TL;DR: The lipid envelope of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an essential component of the virus; however, its molecular composition is undetermined as mentioned in this paper .
Posted ContentDOI
Brief Report: The Virucidal Efficacy of Oral Rinse Components Against SARS-CoV-2 In Vitro
TL;DR: The ability of widely-available mouthwashes to inactivate SARS-CoV-2 in vitro was tested using a protocol capable of detecting a 5-log10 reduction in infectivity, under conditions mimicking the naso/oropharynx.